Abstract:A series of novel modifications were performed at the N(4) position of 5-hydroxyisatin thiosemicarbazone (TSC). The structure-activity approach is applied to design and synthesize derivatives by condensing thiosemicarbazides with 5-hydroxy isatin. The TSCs were characterized by various spectroscopic techniques viz. FTIR, 1H NMR, 13C NMR, UV-Vis, HRMS data, CHN elemental analysis, and single crystal X-ray diffraction. Biological evaluation of the synthesized compounds revealed the anticancer potency of the TSC analogues against breast cancer (MD-AMD-231, MCF-7), lung cancer (A549, NCI-H460), prostate cancer (PC3), and skin cancer (A431). The molecules, L2, L3, and L6 showed activity in the micromolar range (IC50; 0.19-2.19 μM). L6 exhibited the highest potency against skin cancer A431 cell line, with an IC50 of 0.19 μM compared to 1.8 μM with triapine and showed low toxicity against PNT-2 cells with an SI index of >100 μM. The mechanistic study revealed that L6 inhibited cancer cell proliferation, colony formation, and 3-dimensional spheroid formation by targeting the Ras/MAPK axis. It induced DNA damage and impaired DNA damage repair machinery, which led to the accumulation of DSB. Also, it lowered the ERK1/2 expression, which affected the caspase 3 activity and showed higher binding affinity compared to the FDA-approved drug Lenalidomide in molecular docking studies. Our findings demonstrated the possible future anticancer drug potency of L6 in the skin cancer A431 cells.

Synthesis and anti-cancer activity evaluation of 5-(2-carboxyethenyl)-isatin derivatives

Synthesis and cytotoxic studies of novel 5-phenylisatin derivatives and their anti-migration and anti-angiogenic evaluation.

Design, synthesis and biological evaluation of novel 1,5-disubstituted isatin derivatives as antitumor agents

Synthesis and Evaluation of 2-[2-(phenylthiomethyl)-1h-benzo[d] Imidazol-1-yl)acetohydrazide Derivatives As Antitumor Agents

Synthesis and Antitumor Evaluation in Vitro of 5-Bromo-n-phenyl Substituted Isatin Derivatives

Synthesis, in Vitro and in Vivo Antitumor Activity of Symmetrical Bis-Schiff Base Derivatives of Isatin

Synthesis and Antiproliferatory Activities Evaluation of Multi-Substituted Isatin Derivatives

Synthesis and Antitumor Activity of Heterozygous Isatin-Quinazoline Compounds

Synthesis of Isatin-derived Heterocycles with Promising Anticancer Activities

Synthesis of 5-hydroxyisatin thiosemicarbazones, spectroscopic investigation, protein-ligand docking, and in vitro anticancer activity

Synthesis, Characterization And Activity Evaluation Of Matrinic Acid Derivatives As Potential Antiproliferative Agents

Synthesis and in Vitro Anti-Tumor, Anti-Mycobacterial and Anti-HIV Activities of Diethylene-Glycol-Tethered Bis-Isatin Derivatives

Synthesis and Antitumor Evaluation of Novel 5-Hydrosulfonyl-1h-benzo[d]imidazol-2(3h)-one Derivatives.

Synthesis,biological activity evaluation and mechanism of action of novel bis-isatin derivatives as potential anti-liver cancer agents

Synthesis of Novel 5-Nitroisatin Derivatives

Synthesis of novel 4-substituted isatin Schiff base derivatives as potential autophagy inducers and evaluation of their antitumour activity

Synthesis and Antitumor Activity Evaluation of 2-Arylisoquinoline-1,3(2 H, 4 H )-Diones in Vitro and in Vivo

Synthesis and antitumor activity of novel N-substituted tetrahydro-β-carboline-imidazolium salt derivatives.

Novel Thiazolidinone/Thiazolo[3,2-a]Benzimidazolone-Isatin Conjugates as Apoptotic Anti-proliferative Agents Towards Breast Cancer: One-Pot Synthesis and In Vitro Biological Evaluation

Synthesis, biological evaluation and mechanism study of a class of benzylideneindanone derivatives as novel anticancer agents

Synthesis, Fluorescence, and Bioactivity of Novel Isatin Derivatives